Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model
ClinicoEconomics and Outcomes Research · 2025-06 · Volume 17 · 447-453
DOI: 10.2147/ceor.s516583 ↗Kurz gefasst
Fachartikel in der Zeitschrift ClinicoEconomics and Outcomes Research, 2025-06. Verfasst von Tim Smith und 7 weiteren Autor:innen. Beteiligte Einrichtung: Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.
- Department of Psychiatry and Behavioral Sciences, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.
ORCID-Profile: Alec Young, Cameron O'Brien
Zitieren
APA
Smith, T., Young, A., O'Brien, C., Duncan, J., Rashid, M., Magee, T., Fitzgerald, K., & Vassar, M. (2025). Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model. ClinicoEconomics and Outcomes Research, Volume 17, 447-453. https://doi.org/10.2147/ceor.s516583
Vancouver
Smith T, Young A, O'Brien C, Duncan J, Rashid M, Magee T, et al. Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model. ClinicoEconomics and Outcomes Research. 2025;Volume 17:447-453. doi:10.2147/ceor.s516583
BibTeX
@article{Smith2025,
author = {Smith, Tim and Young, Alec and O'Brien, Cameron and Duncan, Jacob and Rashid, Matthew and Magee, Trevor and Fitzgerald, Kyle and Vassar, Matt},
title = {Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model},
journal = {ClinicoEconomics and Outcomes Research},
year = {2025},
volume = {Volume 17},
pages = {447--453},
doi = {10.2147/ceor.s516583}
}
EUVIMED